East Coast Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-380
Closed -$220K 71
2025
Q4
$220K Buy
+380
New +$215K 0.06% 66
2025
Q2
Sell
-404
Closed -$201K 73
2025
Q1
$201K Buy
+404
New +$219K 0.07% 69
2024
Q4
Sell
-380
Closed -$235K 73
2024
Q3
$235K Hold
380
0.08% 69
2024
Q2
$210K Hold
380
0.08% 69
2024
Q1
$221K Hold
380
0.08% 66
2023
Q4
$202K Buy
+380
New +$184K 0.08% 64
2023
Q2
Sell
-380
Closed -$219K 64
2023
Q1
$219K Sell
380
-45
-11% -$25.4K 0.1% 61
2022
Q4
$234K Hold
425
0.12% 58
2022
Q3
$216K Hold
425
0.12% 56
2022
Q2
$231K Hold
425
0.11% 57
2022
Q1
$251K Hold
425
0.06% 59
2021
Q4
$284K Hold
425
0.06% 59
2021
Q3
$243K Hold
425
0.06% 60
2021
Q2
$214K Buy
+425
New +$201K 0.05% 63
2013
Q3
Sell
-691
Closed -$58K 303
2013
Q2
$58K Buy
+691
New +$57.5K 0.03% 215

Other funds holding TMO

East Coast Asset Management's TMO Position: Q1 2026 in Review

East Coast Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 380 shares — an estimated $220K sold.

East Coast Asset Management first reported a position in TMO in Q2 2013 and held it in 15 quarters. The position peaked at $284K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • East Coast Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • East Coast Asset Management sold 380 Thermo Fisher Scientific shares in Q1 2026, an estimated $220K.
  • East Coast Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 15 quarters.
  • East Coast Asset Management's Thermo Fisher Scientific position peaked at $284K in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on East Coast Asset Management's 13F filing for Q1 2026, filed 15 May 2026.